137
Views
5
CrossRef citations to date
0
Altmetric
Clinical Features

Chronic Pelvic Pain Syndrome: A Clinical Enigma

, MD, , MD & , MD

References

  • . Nickel JC, Shoskes D, Wang Y, . How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol. 2006;176(1):119–124
  • . Bullones Rodriguez MA, Afari N, Buchwald DS; National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Urological Chronic Pelvic Pain. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol. 2013;189( 1 Suppl):S66–S74
  • . Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol. 2004;172(3):839–845
  • . Jackson CM, Flies DB, Mosse CA, Parwani A, Hipkiss EL, Drake CG. Strain-specific induction of experimental autoimmune prostatitis (EAP) in mice. Prostate. 2013;73(6):651–656
  • . Penna G, Amuchastegui S, Cossetti C, . Spontaneous and prostatic steroid binding protein peptide-induced autoimmune prostatitis in the nonobese diabetic mouse. J Immunol. 2007;179(3):1559–1567
  • . Shahed AR, Shoskes DA. Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response. J Androl. 2000;21(5):669–675
  • . McVary KT, McKenna KE, Lee C. Prostate innervation. Prostate Suppl. 1998;8:2–13
  • . Yang CC, Lee JC, Kromm BG, Ciol MA, Berger R. Pain sensitization in male chronic pelvic pain syndrome: Why are symptoms so difficult to treat? J Urol. 2003;170(3):823–826; discussion 826–827
  • . Strauss AC, Dimitrakov JD. New treatments for chronic prostatitis/chronic pelvic pain syndrome. Nat Rev Urol. 2010;7(3):127–135
  • . Nickel JC, Shoskes DA. Phenotypic approach to the management of the chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 2010;106(9):1252–1263
  • . Mehik A, Hellstrom P, Sarpola A, Lukkarinen O, Jarvelin MR. Fears, sexual disturbances and personality features in men with prostatitis: a population-based cross-sectional study in Finland. BJU Int. 2001;88(1):35–38
  • . Clemens JQ, Brown SO, Calhoun EA. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol. 2008;180(4):1378–1382
  • . Green MR, Dean AL. Some psychiatric aspects of symptoms of genitourinary disease. J Urol. 1954;72(4):742–747
  • . Mellan J, Raboch J, Kohlicek J. Neurotic symptoms in patients with chronic prostatitis. Cesk Psychiatr. 1972;68(3):145–149
  • . Janssen PL, Kukahn R, Spieler KH, Weissbach L. Psychosomatic studies of chronic prostatitis. Z Psychosom Med Psychoanal. 1983;29(3):253–269
  • . Walz J, Perrotte P, Hutterer G, . Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. BJU Int. 2007;100(6):1307–1311
  • . Tripp DA, Nickel JC, Wang Y, . Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain. 2006;7(10):697–708
  • . George AK, Sadek MA, Saluja SS, Fariello JY, Whitmore KE, Moldwin RM. The impact of neuropathic pain in the chronic pelvic pain population. J Urol. 2012;188(5):1783–1787
  • . Litwin MS. A review of the development and validation of the national institutes of health chronic prostatitis symptom index. Urology. 2002;60( 6 Suppl):14–18; discussion 18–19
  • . Wagenlehner FM, van Till JW, Magri V, . National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol. 2013;63(5):953–959
  • . Hetrick DC, Ciol MA, Rothman I, Turner JA, Frest M, Berger RE. Musculoskeletal dysfunction in men with chronic pelvic pain syndrome type III: a case-control study. J Urol. 2003;170(3):828–831
  • . Clemens JQ, Brown SO, Kozloff L, Calhoun EA. Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis. J Urol. 2006;175(3 Pt 1):963–966; discussion 967
  • . Shoskes DA, Nickel JC, Kattan MW. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology. 2010;75(6):1249–1253
  • . Zhao Z, Zhang J, He J, Zeng G. Clinical utility of the UPOINT phenotype system in Chinese males with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a prospective study. PLoS One. 2013;8(1):e52044
  • . Nickel JC, Downey J, Clark J, . Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology. 2003;62(4):614–617
  • . Tian HL, Zhao D, Ren LM, Su XH, Kang YH. Effects of (-)doxazosin on histomorphologic and cell apoptotic changes of the hyperplastic prostate in castrated rats. Am J Med Sci. 2009;338(3):196–200
  • . Kojima Y, Sasaki S, Oda N, . Prostate growth inhibition by subtype-selective alpha(1)-adrenoceptor antagonist naftopidil in benign prostatic hyperplasia. Prostate. 2009;69(14):1521–1528
  • . Nickel JC, Krieger JN, McNaughton-Collins M, . Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med. 2008;359(25):2663–2673
  • . Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC. Alpha-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 2012;110(7):1014–1022
  • . Tugcu V, Tasci AI, Fazlioglu A, . A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS). Eur Urol. 2007;51(4):1113–1117; discussion 1118
  • . Nickel JC, Pontari M, Moon T, . A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol. 2003;169(4):1401–1405
  • . Nickel JC, Forrest JB, Tomera K, . Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol. 2005;173(4):1252–1255
  • . Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int. 2004;93(7):991–995
  • . Pontari MA, Krieger JN, Litwin MS, . Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med. 2010;170(17):1586–1593
  • . Nickel JC, Atkinson G, Krieger JN, . Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of Tanezumab for chronic prostatitis/chronic pelvic pain syndrome. Urology. 2012;80(5):1105–1110
  • . Chen R, Nickel JC. Acupuncture ameliorates symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. Urology. 2003;61(6):1156–1159; discussion 1159
  • . Anderson RU, Wise D, Sawyer T, Chan C. Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J Urol. 2005;174(1):155–160
  • . Chabal C, Fishbain DA, Weaver M, Heine LW. Long-term transcutaneous electrical nerve stimulation (TENS) use: impact on medication utilization and physical therapy costs. Clin J Pain. 1998;14(1):66–73
  • . Choi NG, Soh SH, Yoon TH, Song MH. Clinical experience with transurethral microwave thermotherapy for chronic nonbacterial prostatitis and prostatodynia. J Endourol. 1994;8(1):61–64
  • . Nickel JC, Sorenson R. Transurethral microwave thermotherapy of nonbacterial prostatitis and prostatodynia: Initial experience. Urology. 1994;44(3):458–460
  • . Stein A, Dekel Y. Chronic prostatitis and chronic pelvic pain syndrome. Harefuah. 2012;151(9):541–544, 555
  • . Kastner C, Hochreiter W, Huidobro C, Cabezas J, Miller P. Cooled transurethral microwave thermotherapy for intractable chronic prostatitis—results of a pilot study after 1 year. Urology. 2004;64(6):1149–1154
  • . Barza M. Anatomical barriers for antimicrobial agents. Eur J Clin Microbiol Infect Dis. 1993;12( Suppl 1):S31–S35
  • . El-Hakim A. Chronic prostatitis/chronic pelvic pain syndrome: Is there a role for local drug infiltration therapy? J Endourol. 2004;18(3):227–231
  • . Zermann D, Ishigooka M, Schubert J, Schmidt RA. Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? Eur Urol. 2000;38(4):393–399
  • . Apostolidis A, Fowler CJ. The use of botulinum neurotoxin type A (BoNTA) in urology. J Neural Transm. 2008;115(4):593–605
  • . Chuang YC, Yoshimura N, Huang CC, Wu M, Chiang PH, Chancellor MB. Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. J Urol. 2008;180(2):742–748
  • . Zimmermann R, Cumpanas A, Miclea F, Janetschek G. Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study. Eur Urol. 2009;56(3):418–424
  • . Faris G, Metz Y, Friedman B, Appel B, Stein A. Prostatic abscess—diagnosis and treatment. Harefuah. 2008;147(7):594–596, 663

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.